✦ LIBER ✦

TAXANE-CISPLATIN-5FU AS INDUCTION CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA: AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF THE MACH-NC GROUP

✍ Scribed by P. Blanchard; A. Bourredjem; J. Bourhis; R. Hitt; M. Posner; J. Vermorken; G. Calais; A. Paccagnella; J.P. Pignong

Book ID: 119518624
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 292 KB
Volume: 98
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(11)70005-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxane-Cisplatin-Fluorouracil As Inducti

Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer Group

✍ Blanchard, P.; Bourhis, J.; Lacas, B.; Posner, M. R.; Vermorken, J. B.; Hernande 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 187 KB

Chemotherapy in locally advanced head an

Chemotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): Preliminary results of a meta-analysis using individual patient data of randomized trials

✍ Pignon, J.P.; Designé, L.; Bourhis, J.; Domenge, C.; Guérin, S.; Luboinski, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 225 KB

Chemotherapy added to locoregional treat

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer

✍ J.P Pignon; J Bourhis; C Domenge; L Designe 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 20 KB

Docetaxel, cisplatin, and 5-fluorouracil

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck : The Dana Farber Cancer Institute experience

✍ Robert Haddad; A. Dimitrios Colevas; Roy Tishler; Paul Busse; Laura Goguen; Chri 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Abstract ## BACKGROUND The authors conducted a series of four Phase I–II trials of high‐dose and intermediate‐dose docetaxel, cisplatin, and 5‐fluorouracil (TPF)‐based induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime

PCN38 COST-EFFECTIVENES ANALYSIS OF DOCE

PCN38 COST-EFFECTIVENES ANALYSIS OF DOCETAXEL VERSUS STANDARD REGIMEN AS THE INDUCTION CHEMOTHERAPY OF LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA IN POLAND

✍ J Walczak; K Lasota; I Malczak; D Pawlik; A Semeniuk; A Simon; M Bryl; J Lis; G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

8533 POSTER First Results of an Uncontro

8533 POSTER First Results of an Uncontrolled, Phase II Trial of Induction Chemotherapy With Cetuximab and Docetaxel-Cisplatin-5FU Followed by Cetuximab+Radiotherapy in the Responders in Locally Advanced Resectable Squamous Cell Cancer of the Head and Neck

✍ Remenar, E.; Lövey, J.; Koltai, P.; Horvath, K.; Gödeny, M.; Kasler, M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB